Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins

Journal of Lipid Research

Volumn 47, Issue 8, 2006, Pages 1749-1761

  Qiu, Wei ^a   Avramoglu, Rita Kohen ^a   Rutledge, Angela C ^a   Tsai, Julie ^a   Adeli, Khosrow ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Apolipoprotein B degredation; Glycosylation; Hepatocytes; Proteasome; Very low density lipoprotein

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN B100; DEFEROXAMINE; GLUCOSAMINE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROTEASOME; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; BIOGENESIS; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HUMAN; HUMAN CELL; LIPOPROTEIN SECRETION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; STRESS;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CELLS, CULTURED; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE; GLYCOSYLATION; HEPATOCYTES; HUMANS; LEUPEPTINS; OLEIC ACID; OLIGOSACCHARIDES; PROTEIN TRANSPORT; RATS; TUMOR CELLS, CULTURED;

EID: 33747144535     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500363-JLR200     Document Type: Article

References (33)

1. Kohen Avramoglu, R., W. Qiu, and K. Adeli. 2003. Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion. Front. Biosci. 8: d464-d476.
2. Fisher, E. A., and H. N. Ginsberg. 2002. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J. Biol. Chem. 277: 17377-17380.
3. Adeli, K. 1994. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells. J. Biol. Chem. 269: 9166-9175.
4. Cavallo, D., D. Rudy, A. Mohammadi, J. Macri, and K. Adeli. 1999. Studies on degradative mechanisms mediating post-translational fragmentation of apolipoprotein B and the generation of the 70-kDa fragment. J. Biol. Chem. 274: 23135-23143.
5. Fisher, E. A., M. Pan, X. Chen, X. Wu, H. Wang, H. Jamil, J. D. Sparks, and K. J. Williams. 2001. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 276: 27855-27863.
6. Yao, Z., and R. S. McLeod. 1994. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim. Biophys. Acta. 1212: 152-166.
7. Cartwright, I. J., and J. A. Higgins. 1996. Intracellular degradation in the regulation of secretion of apolipoprotein B-100 by rabbit hepatocytes. Biochem. J. 314: 977-984.
8. Taghibiglou, C., D. Rudy, S. C. Van Iderstine, A. Aiton, D. Cavallo, R. Cheung, and K. Adeli. 2000. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes. J. Lipid Res. 41: 499-513.
9. Wang, H., X. Chen, and E. A. Fisher. 1993. N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J. Clin. Invest. 91: 1380-1389.
10. Tran, K., G. Thorne-Tjomsland, C. J. DeLong, Z. Cui, J. Shan, L. Burton, J. C. Jamieson, and Z. Yao. 2002. Intracellular assembly of very low density lipoproteins containing apolipoprotein B100 in rat hepatoma McA-RH7777 cells. J. Biol. Chem. 277: 31187-31200.
11. Mitchell, D. M., M. Zhou, R. Pariyarath, H. Wang, J. D. Aitchison, H. N. Ginsberg, and E. A. Fisher. 1998. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence. Proc. Natl. Acad. Sci. USA. 95: 14733-14738.
12. Yamaguchi, J., M. V. Gamble, D. Conlon, J. S. Liang, and H. N. Ginsberg. 2003. The conversion of apoB100 low density lipoprotein/high density lipoprotein particles to apoB100 very low density lipoproteins in response to oleic acid occurs in the endoplasmic reticulum and not in the Golgi in McA RH7777 cells. J. Biol. Chem. 278: 42643-42651.
13. Gordon, D. A., H. Jamil, D. Sharp, D. Mullaney, Z. Yao, R. E. Gregg, and J. Wetterau. 1994. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc. Natl. Acad. Sci. USA. 91: 7628-7632.
14. Gordon, D. A., H. Jamil, R. E. Gregg, S. O. Olofsson, and J. Boren. 1996. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step. J. Biol. Chem. 271: 33047-33053.
15. Rustaeus, S., P. Stillemark, K. Lindberg, D. Gordon, and S. O. Olofsson. 1998. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells. J. Biol. Chem. 273: 5196-5203.
16. Wang, Y., R. S. McLeod, and Z. Yao. 1997. Normal activity of microsomal triglyceride transfer protein is required for the oleate-induced secretion of very low density lipoproteins containing apolipoprotein B from McA-RH7777 cells. J. Biol. Chem. 272: 12272-12278.
17. Pan, M., A. I. Cederbaum, Y. L. Zhang, H. N. Ginsberg, K. J. Williams, and E. A. Fisher. 2004. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113: 1277-1287.
18. Zhang, J., and H. Herscovitz. 2003. Nascent lipidated apolipoprotein B is transported to the Golgi as an incompletely folded intermediate as probed by its association with network of endoplasmic reticulum molecular chaperones, GRP94, ERp72, BiP, calreticulin, and cyclophilin B. J. Biol. Chem. 278: 7459-7468.
19. Adeli, K., J. Macri, A. Mohammadi, M. Kito, R. Urade, and D. Cavallo. 1997. Apolipoprotein B is intracellularly associated with an ER-60 protease homologue in HepG2 cells. J. Biol. Chem. 272: 22489-22494.
20. Qiu, W., R. Kohen Avramoglu, S. Mhapsekar, J. Tsai, R. C. Austin, and K. Adeli. 2005. Glucosamine-induced endoplasmic reticulum stress promotes apoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation. Arterioscler. Thromb. Vasc. Biol. 25: 571-577.
21. Buse, M. G. 2006. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 290: E1-E8.
22. Werstuck, G. H., M. I. Khan, G. Femia, A. J. Kim, V. Tedesco, B. Trigatti, and Y. Shi. 2006. Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes. 55: 93-101.
23. Qiu, W., R. Kohen Avramoglu, F. Rashid-Kolvear, C. S. Au, T. M. Chong, G. F. Lewis, D. K. Trinh, R. C. Austin, R. Urade, and K. Adeli. 2004. Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway. Biochemistry. 43: 4819-4831.
24. Qiu, W., R. Kohen Avramoglu, N. Dube, T. M. Chong, M. Naples, C. Au, K. G. Sidiropoulos, G. F. Lewis, J. S. Cohn, M. L. Tremblay, et al. 2004. Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies. Diabetes. 53: 3057-3066.
25. Elbein, A. D. 1984. Inhibitors of the biosynthesis and processing of N-linked oligosaccharides. CRC Crit. Rev. Biochem. 16: 21-49.
26. Vukmirica, J., T. Nishimaki-Mogami, K. Tran, J. Shan, R. S. McLeod, J. Yuan, and Z. Yao. 2002. The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL. J. Lipid Res. 43: 1496-1507.
27. McMillan, D. R., M. J. Gething, and J. Sambrook. 1994. The cellular response to unfolded proteins: intercompartmental signaling. Curr. Opin. Biotechnol. 5: 540-545.
28. Poolsup, N., C. Suthisisang, P. Channark, and W. Kittikulsuth. 2005. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann. Pharmacother. 39: 1080-1087.
29. Towheed, T. E., L. Maxwell, T. P. Anastassiades, B. Shea, J. Houpt, V. Robinson, M. C. Hochberg, and G. Wells. 2005. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst. Rev. CD002946.
30. Bailey, C. J., and S. L. Turner. 2004. Glucosamine-induced insulin resistance in L6 muscle cells. Diabetes Obes. Metab. 6: 293-298.
31. Spampinato, D., A. Giaccari, V. Trischitta, B. V. Costanzo, L. Morviducci, A. Buongiorno, U. Di Mario, R. Vigneri, and L. Frittitta. 2003. Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation. Metabolism. 52: 1092-1095.
32. Adeli, K., C. Taghibiglou, S. C. Van Iderstine, and G. F. Lewis. 2001. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc. Med. 11: 170-176.
33. Lin, H. Y., P. Masso-Welch, Y. P. Di, J. W. Cai, J. W. Shen, and J. R. Subjeck. 1993. The 170-kDa glucose-regulated stress protein is an endoplasmic reticulum protein that binds immunoglobulin. Mol. Biol. Cell. 4: 1109-1119.